SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-24-093194
Filing Date
2024-04-11
Accepted
2024-04-11 16:05:38
Documents
18
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d807955d10ka.htm   iXBRL 10-K/A 147521
2 EX-31.3 d807955dex313.htm EX-31.3 2486
3 EX-31.4 d807955dex314.htm EX-31.4 2480
9 GRAPHIC g807955g0411195028107.jpg GRAPHIC 1550
  Complete submission text file 0001193125-24-093194.txt   402584

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mrk-20231231.xsd EX-101.SCH 5378
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mrk-20231231_cal.xml EX-101.CAL 654
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrk-20231231_def.xml EX-101.DEF 19838
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrk-20231231_lab.xml EX-101.LAB 25934
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrk-20231231_pre.xml EX-101.PRE 20847
21 EXTRACTED XBRL INSTANCE DOCUMENT d807955d10ka_htm.xml XML 11834
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-06571 | Film No.: 24838538
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)